From the dark annals of Erowid forums to Joe Rogan’s podcast studio, there’s perhaps no psychoactive drug more enigmatic — and misunderstood — than N,N-Dimethyltryptamine, better known as DMT. The ...
Biomind Labs Inc. BMNDF, a life sciences company developing medicinal next-generation psychedelics, completed the dose administration of 30 healthy subjects within its Phase 2 clinical trial of ...
- Negative predictive value (NPV) higher than 99% regardless of skin type Using follow-up information and biopsy results from a large registry database that also served as the basis for the Company’s ...
A Canadian-based pharmaceutical company has received approval to conduct a clinical study of the psychedelic compound DMT as a treatment for stroke. Under the plan, pharmaceutical development company ...
LA JOLLA, Calif.--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced ...
SAN DIEGO--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today reported positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results